Welcome to our dedicated page for VSee Health SEC filings (Ticker: VSEE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Locating reimbursement risks, HIPAA exposure, and remote-patient-monitoring metrics inside VSee Health’s dense disclosures can feel like telehealth without broadband—slow and frustrating. The company’s filings stretch across hundreds of pages and multiple form types, yet each paragraph can materially shift your view of its subscription revenue, data-security posture, or partnership pipeline.
Stock Titan solves that problem. Our platform delivers AI-powered summaries that turn the VSee Health annual report 10-K simplified into a concise brief, flags every VSee Health Form 4 insider transactions real-time, and highlights section-by-section changes in the latest VSee Health quarterly earnings report 10-Q filing. If you have ever typed "understanding VSee Health SEC documents with AI" or searched for "VSee Health insider trading Form 4 transactions," this page was built for you.
- Instant alerts when executives file VSee Health executive stock transactions Form 4
- Contextual redlines that compare revenue growth and R&D spend across quarters for faster VSee Health earnings report filing analysis
- Plain-English explanations of each VSee Health 8-K material events explained
- Deep dives into the VSee Health proxy statement executive compensation so you can track incentive alignment
Every document—10-K, 10-Q, 8-K, S-1, or insider trade—appears on this page moments after it hits EDGAR, complete with expert commentary. No more hunting through footnotes to grasp how new CMS rules might impact telehealth revenue. With real-time filing updates and clear takeaways, Stock Titan lets you act on critical information while others are still scrolling.
Dominion-led investor group reports beneficial ownership of 1,816,389 shares of VSEE Health common stock, representing roughly 9.9% of the class. The filing covers nine reporting persons including Dominion Capital LLC, related entities and individuals Mikhail and Gennadiy Gurevich and Alon Brenner. The percentage calculations reference 16,422,690 shares outstanding as of August 27, 2025, plus 600,000 shares converted on September 3, 2025, for a total of 17,022,690 shares. The reported position includes shares issuable upon conversion of convertible notes and upon exercise of warrants held by Dominion and Ascent, each of which is subject to a 9.99% beneficial ownership limitation (the "Blocker"). The filing notes specific conversion/exercise amounts: Dominion's convertible notes convert into 1,626,022 shares and its warrants into 173,913 shares; Ascent's convertible note converts into 1,111,112 shares and its warrants into 740,741 shares. The group certifies the holdings were not acquired to change or influence control of the issuer.
VSee Health, Inc. (VSEE) amended its 2024 annual report to correct multiple accounting errors, restate interim periods and disclose material financing and acquisition activity. The company identified repeated failures to accrue sales and use taxes, resulting in cumulative accrual increases peaking at $940,130 as of September 30, 2024, and multiple revenue cutoff corrections that moved revenue to deferred revenue and opening retained earnings. The firm recorded substantial purchase accounting adjustments tied to the June 24, 2024 business combination and iDoc acquisition, including adjustments to goodwill and acquired receivables that led to a significant goodwill impairment charge of $56,675,210 and a net loss of $58,134,446 for the year. Financing activity includes an Exchange Note of $2,523,744, a $3,000,000 Quantum Convertible Note, and an Equity Line (ELOC) commitment up to $50,000,000 (floor price later amended). The filing also discloses defaults, numerous convertible and original-issue-discount notes, material fair-value remeasurements, and explicit risks including uncertainty about continuing as a going concern.
VSee Health, Inc. reported a complex 2024 marked by a June 24, 2024 business combination that closed with the acquisition of iDoc and the conversion of legacy securities into the Company’s common stock. Goodwill at closing was $61,591,904 and accumulated goodwill impairment charges reached $56,675,210, contributing to a consolidated net loss of $58,134,446. The Company disclosed a series of accounting restatements and corrections—including recurring failures to accrue sales and use taxes (totaling up to $940,130 as of Sept 30, 2024), revenue cutoff adjustments, and multiple post‑closing accrual errors—that affected retained earnings, deferred revenue and operating expense in 2023 and 2024.
The Company secured multiple financing arrangements: an Equity Purchase Agreement (ELOC) providing up to $50,000,000 in aggregate proceeds (floor price amended to $1.25 on March 20, 2025), an Exchange Note of $2,523,744, and a $3,000,000 Quantum Convertible Note. Several acquired promissory notes and factoring arrangements remain outstanding and some iDoc notes are in default, and management disclosed uncertainty about continuing as a going concern.
FAQ
What is the current stock price of VSee Health (VSEE)?
What is the market cap of VSee Health (VSEE)?
